Evidence map›Paper›PMID 35088214›Full record

ArticlePlant foods for human nutrition (Dordrecht, Netherlands)2022

Red-Beet Betalain Pigments Inhibit Amyloid-β Aggregation and Toxicity in Amyloid-β Expressing Caenorhabditis elegans.

Tomohiro Imamura, Noriyoshi Isozumi, Yasuki Higashimura, Hironori Koga, Tenta Segawa, Natsumi Desaka, Hiroki Takagi, Kenji Matsumoto, Shinya Ohki, Masashi Mori

Abstract read
PubMed Publisher
In one paragraph

Article in Plant foods for human nutrition (Dordrecht, Netherlands), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Identification ofPlant biotechnology (Tokyo, Japan) · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tomohiro ImamuraResearch Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, 308-1 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan. timamura@ishikawa-pu.ac.jp.ORCID http://orcid.org/0000-0003-2277-9134
Noriyoshi IsozumiCenter for Nano Materials and Technology (CNMT), Japan Advanced Institute of Science and Technology (JAIST), 1-1 Asahidai, Nomi, Ishikawa, 923-1292, Japan.ORCID https://orcid.org/0000-0002-2077-7576
Yasuki HigashimuraDepartment of Food Science, Ishikawa Prefectural University, 308-1 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan.ORCID https://orcid.org/0000-0003-0540-4306
Hironori KogaDepartment of Bioproduction Science, Ishikawa Prefectural University, 308-1 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan.ORCID https://orcid.org/0000-0002-7611-6267
Tenta SegawaDepartment of Bioproduction Science, Ishikawa Prefectural University, 308-1 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan.
Natsumi DesakaDepartment of Food Science, Ishikawa Prefectural University, 308-1 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan.
Hiroki TakagiDepartment of Bioproduction Science, Ishikawa Prefectural University, 308-1 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan.ORCID https://orcid.org/0000-0002-8576-9892
Kenji MatsumotoDepartment of Food Science, Ishikawa Prefectural University, 308-1 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan.ORCID https://orcid.org/0000-0001-6609-0545
Shinya OhkiCenter for Nano Materials and Technology (CNMT), Japan Advanced Institute of Science and Technology (JAIST), 1-1 Asahidai, Nomi, Ishikawa, 923-1292, Japan.ORCID https://orcid.org/0000-0002-5497-7277
Masashi MoriResearch Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, 308-1 Suematsu, Nonoichi, Ishikawa, 921-8836, Japan. mori@ishikawa-pu.ac.jp.ORCID https://orcid.org/0000-0002-9021-8104
Ishikawa Prefectural University · JPJapan Advanced Institute of Science and Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Betalain pigments are mainly produced by plants belonging to the order of Caryophyllales. Betalains exhibit strong antioxidant activity and responds to environmental stimuli and stress in plants. Recent reports of antioxidant, anti-inflammatory and anti-cancer properties of betalain pigments have piqued interest in understanding their biological functions. We investigated the effects of betalain pigments (betanin and isobetanin) derived from red-beet on amyloid-β (Aβ) aggregation, which causes Alzheimer's disease. Non-specific inhibition of Aβ aggregation against Aβ40 and Aβ42 by red-beet betalain pigments, in vitro was demonstrated using the thioflavin t fluorescence assay, circular dichroism spectroscopy analysis, transmission electron microscopy and nuclear magnetic resonance (NMR) analysis. Furthermore, we examined the ability of red-beet betalain pigments to interfere with Aβ toxicity by using the transgenic Caenorhabditis elegans model, which expresses the human Aβ42 protein intracellularly within the body wall muscle. It responds to Aβ-toxicity with paralysis and treatment with 50 μM red-beet betalain pigments significantly delayed the paralysis of C. elegans. These results suggest that betalain pigments reduce Aβ-induced toxicity.

Indexed as

BetalainsBeta vulgarisAmyloid beta-PeptidesAnimalsAntioxidantsCaenorhabditis elegansParalysisAmyloid beta-PeptidesAntioxidantsBetalainsAmyloid-betaCaenorhabditis elegansCircular dichroism spectroscopyNuclear magnetic resonanceRed-beet betalain pigmentsThioflavin t fluorescence assayTransmission electron microscopy

Identifiers

PMID35088214
OpenAlexW4221078207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.